Multiple myeloma (MM), a complex form of blood cancer originating in plasma cells, relentlessly impairs blood counts and immune functions. Despite breakthroughs in treatment modalities, MM largely remains incurable, with patients often enduring cycles of remission interrupted by relapses. This
The Institute of Cancer Research (ICR) in London is teaming up with Healx, a biotech firm known for its expertise in artificial intelligence (AI) and machine learning, to develop potential new therapies for diffuse intrinsic pontine glioma (DIPG), a rare and currently untreatable form of childhood
In recent years, significant advancements have been made in treating pediatric acute lymphocytic leukemia (B-ALL) through combining traditional chemotherapy with innovative drugs like blinatumomab. This blend of treatments, examined in a clinical trial, has shown promising results, particularly in
Government Funding Bill Removes Pediatric Cancer Research Program In a surprising turn of events, the recent changes in the U.S. government's temporary funding bill have sparked controversy, as funding for pediatric cancer research has been excluded. The new bill, aimed at preventing a
The fight against hepatocellular carcinoma (HCC) has seen a significant breakthrough with the release of new findings from the NRG-RTOG 1112 Phase III clinical study. This study explored the effects of adding stereotactic body radiotherapy (SBRT) to the existing systemic therapy with sorafenib for
Recent policy reforms in Washington are set to bring significant changes to the field of nuclear imaging, with the Society of Nuclear Medicine and Molecular Imaging (SNMMI) playing a crucial role in pushing for these advancements. These policies aim to address everything from reimbursement rates
